Jong Ook Lee

Title: Innovations of Jong Ook Lee

Introduction

Jong Ook Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments and imaging methods for cancer.

Latest Patents

Jong Ook Lee holds 2 patents that showcase his expertise and innovative spirit. His latest patents include a modified nucleic acid that has improved treatment efficacy, as well as an anticancer pharmaceutical composition containing the same. The oligonucleotide variant described in his patent exhibits excellent in-vivo stability and anticancer effects, represented by the structure of Formula 1: (N)-[TGG][TTG][TGG]-(M). Additionally, he has developed a biomolecule imaging method using an aptamer. This method involves a composition for imaging a tumorous disease region, which includes a fluorescence- or radioactive isotope-labeled ERBB2 aptamer. The labeled aptamer is utilized to image the tumorous disease region in vivo, enhancing the accuracy of cancer diagnostics.

Career Highlights

Jong Ook Lee is currently associated with Interoligo Corporation, where he continues to push the boundaries of cancer research and treatment. His work has garnered attention for its potential to improve patient outcomes through innovative therapeutic strategies.

Collaborations

Some of his notable coworkers include Jung Hwan Lee and Jong In Kim, who contribute to the collaborative efforts in advancing their research initiatives.

Conclusion

Jong Ook Lee's contributions to the field of biotechnology through his patents and collaborative work highlight his commitment to innovation in cancer treatment and diagnostics. His ongoing research promises to make a significant impact in the medical community.